The improvement effect of ellagic acid and urolithins on metabolic diseases: Pharmacology and mechanism

Saklayen, M. G. The global epidemic of the metabolic syndrome. Current Hypertension Reports, 2018, 20: 12. https://doi.org/10.1007/s11906-018-0812-z

Huang, P. L. A comprehensive definition for metabolic syndrome. Disease Models & Mechanisms, 2009, 2: 231–237. https://doi.org/10.1242/dmm.001180

Fletcher, B., Gulanick, M., Lamendola, C. Risk factors for type 2 diabetes mellitus. The Journal of Cardiovascular Nursing, 2002, 16: 17–23. https://doi.org/10.1097/00005082-200201000-00003

Cho, N. H., Shaw, J. E., Karuranga, S., et al. IDF diabetes atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Research and Clinical Practice, 2018, 138: 271–281. https://doi.org/10.1016/j.diabres.2018.02.023

van den Arend, I. J., Stolk, R. P., Krans, H. M., et al. Management of type 2 diabetes: a challenge for patient and physician. Patient Education and Counseling, 2000, 40: 187–194. https://doi.org/10.1016/s0738-3991(99)00067-1

Zhang, J., He, X., Zhang, L., et al. Association of severe hypoglycemia with all-cause mortality and complication risks among patients with type 2 diabetes mellitus in China. Diabetes Research and Clinical Practice, 2020, 170: 108493. https://doi.org/10.1016/j.diabres.2020.108493

Shou, J. W., Shaw, P. C. Berberine reduces lipid accumulation in obesity via mediating transcriptional function of PPARδ. International Journal Of Molecular Sciences, 2023, 24: 11600. https://doi.org/10.3390/ijms241411600

Csige, I., Ujvárosy, D., Szabó, Z., et al. The impact of obesity on the cardiovascular system. Journal of diabetes research, 2018, 2018: 3407306. https://doi.org/10.1155/2018/3407306

Boutari, C., DeMarsilis, A., Mantzoros, C. S. Obesity and diabetes. Diabetes Research and Clinical Practice Diabetes, 2023, 202: 110773. https://doi.org/10.1016/j.diabres.2023.110773

Polyzos, S. A., Kountouras, J., Mantzoros, C. S. Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics. Metabolism: clinical and experimental, 2019, 92: 82–97. https://doi.org/10.1016/j.metabol.2018.11.014

Seravalle, G., Grassi, G. Obesity and hypertension. Pharmacological Research, 2017, 122: 1–7. https://doi.org/10.1016/j.phrs.2017.05.013

Kaneko, K., Aoyagi, Y., Fukuuchi, T., et al. Total purine and purine base content of common foodstuffs for facilitating nutritional therapy for gout and hyperuricemia. Biological and Pharmaceutical Bulletin, 2014, 37: 709–721. https://doi.org/10.1248/bpb.b13-00967

Wang, R. W., Tian, H. L., Guo, D. D., et al. Impacts of exercise intervention on various diseases in rats. Journal of Sport and Health Science, 2020, 9: 211–227. https://doi.org/10.1016/j.jshs.2019.09.008

Kathuria, D., Raul, A. D., Wanjari, P., et al. Biguanides: Species with versatile therapeutic applications. European Journal of Medecinal Chemistry, 2021, 219: 113378. https://doi.org/10.1016/j.ejmech.2021.113378

Xie, L., Xia, W. Characteristics and molecular mechanisms through which SGLT2 inhibitors improve metabolic diseases: A mechanism review. Life Sciences, 2022, 300: 120543. https://doi.org/10.1016/j.lfs.2022.120543

Mohri, T., Okamoto, S., Nishioka, Y., et al. Risk of lactic acidosis in hospitalized diabetic patients prescribed biguanides in Japan: A retrospective total-population cohort study. International Journal of Environment Research and Public Health, 2023, 20: 5300. https://doi.org/10.3390/ijerph20075300

Wallemacq, C. Statins and new-onset diabetes : Benefit-risk balance. Revue Medicale Suisse, 2019, 15: 1454–1457. https://doi.org/10.53738/REVMED.2019.15.659.1454

Taylor, S. I., Blau, J. E., Rother, K. I. SGLT2 inhibitors may predispose to ketoacidosis. Journal of Clinical Endocrinology & Metabolism, 2015, 100: 2849–2852. https://doi.org/10.1210/jc.2015-1884

Dave, C. V., Schneeweiss, S., Kim, D., et al. Sodium-glucose cotransporter-2 inhibitors and the risk for severe urinary tract infections: A population-based cohort study. Annals of Internal Medicine, 2019, 171: 248–256. https://doi.org/10.7326/m18-3136

Xu, J. D., Zhang, J. L., Sang, Y. M., et al. Polysaccharides from medicine and food homology materials: A review on their extraction, purification, structure, and biological activities. Molecules, 2022, 27: 3215. https://doi.org/10.3390/molecules27103215

Lu, Q., Li, R., Yang, Y., et al. Ingredients with anti-inflammatory effect from medicine food homology plants. Food Chemistry, 2022, 368: 130610. https://doi.org/10.1016/j.foodchem.2021.130610

Gong, X., Ji, M. Y., Xu, J. P., et al. Hypoglycemic effects of bioactive ingredients from medicine food homology and medicinal health food species used in China. Critical Reviews in Food Science and Nutrition, 2020, 60: 2303–2326. https://doi.org/10.1080/10408398.2019.1634517

Huang, Y. Q., Liang, W., Li, K., et al. Sorafenib suppresses the activation of type I interferon pathway induced by RLR-MAVS and cGAS-STING signaling. Biochemical and Biophysical Research Communications, 2022, 623: 181–188. https://doi.org/10.1016/j.bbrc.2022.07.028

Li, R. L., Wang, J., Liu, J. Y., et al. Mulberry leaf and its effects against obesity: A systematic review of phytochemistry, molecular mechanisms and applications. Phytomedicine, 2024, 128: 155528. https://doi.org/10.1016/j.phymed.2024.155528

Kim D. H., Sim Y., Hwang J. H., et al. Ellagic acid prevents binge alcohol-induced leaky gut and liver injury through inhibiting gut dysbiosis and oxidative stress. Antioxidants (Basel), 2021, 10: 1386. https://doi.org/10.3390/antiox10091386

Derosa, G., Maffioli, P., Sahebkar, A. Ellagic acid and its role in chronic diseases. Advances in Experimental Medicine and Biology, 2016, 928: 473–479. https://doi.org/10.1007/978-3-319-41334-1_20

Ceci, C., Lacal, P. M., Tentori, L., et al. Experimental evidence of the antitumor, antimetastatic and antiangiogenic activity of ellagic acid. Nutrients, 2018, 10: 1756. https://doi.org/10.3390/nu10111756

Ding, X. Q., Jian, T. Y., Wu, Y. X., et al. Ellagic acid ameliorates oxidative stress and insulin resistance in high glucose-treated HepG2 cells via miR-223/keap1-Nrf2 pathway. Biomedicine & pharmacotherapy, 2019, 110: 85–94. https://doi.org/10.1016/j.biopha.2018.11.018

Baradaran Rahimi, V., Ghadiri, M., Ramezani, M., et al. Antiinflammatory and anti-cancer activities of pomegranate and its constituent, ellagic acid: Evidence from cellular, animal, and clinical studies. Phytotherapy Research, 2020, 34: 685–720. https://doi.org/10.1002/ptr.6565

Vanella, L., Di Giacomo, C., Acquaviva, R., et al. Effects of ellagic acid on angiogenic factors in prostate cancer cells. Cancers (Basel), 2013, 5: 726–738. https://doi.org/10.3390/cancers5020726

Wu, S., Tian, L. A new flavone glucoside together with known ellagitannins and flavones with anti-diabetic and anti-obesity activities from the flowers of pomegranate ( Punica granatum). Natural Product Research, 2019, 33: 252–257. https://doi.org/10.1080/14786419.2018.1446009

BenSaad, L. A., Kim, K. H., Quah, C. C., et al. Anti-inflammatory potential of ellagic acid, gallic acid and punicalagin A&B isolated from Punica granatum. BMC Complementary and Alternative Medicine, 2017, 17: 47. https://doi.org/10.1186/s12906-017-1555-0

Alfei, S., Turrini, F., Catena, S., et al. Ellagic acid a multi-target bioactive compound for drug discovery in CNS? A narrative review. European Journal of Medicinal Chemistry, 2019, 183: 111724. https://doi.org/10.1016/j.ejmech.2019.111724

Sun, Y. L., Zhou, F. M., Wang, H. R. Mechanism of pomegranate ellagic polyphenols reducing insulin resistance on gestational diabetes mellitus rats. American Journal of Translational Research, 2019, 11: 5487–5500.

Núñez, S., Moliner, C., Valero, M. S., et al. Antidiabetic and anti-obesity properties of a polyphenol-rich flower extract from Tagetes erecta L. and its effects on Caenorhabditis elegans fat storages. Journal of Physiology and Biochemistry, 2023, 79: 427–440. https://doi.org/10.1007/s13105-023-00953-5

Sun, Z. R., Liu, H. R., Hu, D., et al. Ellagic acid exerts beneficial effects on hyperuricemia by inhibiting xanthine oxidase and NLRP3 inflammasome activation. Journal of agricultural and food chemistry, 2021, 69: 12741–12752. https://doi.org/10.1021/acs.jafc.1c05239

García-Villalba, R., Giménez-Bastida, J. A., Cortés-Martín, A., et al. Urolithins: A comprehensive update on their metabolism, bioactivity, and associated gut microbiota. Molecular nutrition & food research, 2022, 66: e2101019. https://doi.org/10.1002/mnfr.202101019

Djedjibegovic, J., Marjanovic, A., Panieri, E., et al. Ellagic acid-derived urolithins as modulators of oxidative stress. Oxidative medicine and cellular longevity, 2020, 2020: 5194508. https://doi.org/10.1155/2020/5194508

Guo, S., Ren, X., He, K., et al. The anti-diabetic effect of eight Lagerstroemia speciosa leaf extracts based on the contents of ellagitannins and ellagic acid derivatives. Food & Function, 2020, 11: 1560–1571. https://doi.org/10.1039/c9fo03091c

Yang, Y., Lee, P. K., Wong, H. C., et al. Oral supplementation of Gordonibacter urolithinfaciens promotes ellagic acid metabolism and urolithin bioavailability in mice. Food Chemistry, 2024, 437: 137953. https://doi.org/10.1016/j.foodchem.2023.137953

Kang, I., Buckner, T., Shay, N. F., et al. Improvements in metabolic health with consumption of ellagic acid and subsequent conversion into urolithins: Evidence and mechanisms. Advances in Nutrition, 2016, 7: 961–972. https://doi.org/10.3945/an.116.012575

Braconnot H. Observations sur la préparation et la purification de l′acide gallique, et sur l′existence d′un acide nouveau dans la noix de galle. Annales de Chimie et de Physique, 1818, 9: 181–189.

Evtyugin, D. D., Magina, S., Evtuguin, D. V. Recent advances in the production and applications of ellagic acid and its derivatives. A review. Molecules, 2020, 25: 2745. https://doi.org/10.3390/molecules25122745

Daniel, E. M., Krupnick, A. S., Heur, Y. H., et al. Extraction, stability, and quantitation of ellagic acid in various fruits and nuts. Journal of Food Composition and Analysis, 1989, 2: 338–349. https://doi.org/10.1016/0889-1575(89)90005-7

Umar A., Khan M. T., Bukhari S., et al. Antioxidant activity and total phenolic contents of dried and germinated legumes. Research Square, 2022, 2022: 1–13. https://doi.org/10.21203/rs.3.rs-1239490/v1

Fracassetti, D., Costa, C., Moulay, L., et al. Ellagic acid derivatives, ellagitannins, proanthocyanidins and other phenolics, vitamin C and antioxidant capacity of two powder products from camu-camu fruit ( Myrciaria dubia). Food Chemistry, 2013, 139: 578–588. https://doi.org/10.1016/j.foodchem.2013.01.121

García-Villalba, R., Espín, J. C., Aaby, K., et al. Validated method for the characterization and quantification of extractable and nonextractable ellagitannins after acid hydrolysis in pomegranate fruits, juices, and extracts. Journal of Agricultural and Food Chemistry, 2015, 63: 6555–6566. https://doi.org/10.1021/acs.jafc.5b02062

Kyriakoudi, A., Kalfa, E., Zymvrakaki, E., et al. Recovery of ellagic acid from pomegranate peels with the aid of ultrasound-assisted alkaline hydrolysis. Molecules, 2024, 29: 2424. https://doi.org/10.3390/molecules29112424

Benchagra, L., Berrougui, H., Islam, M. O., et al. Antioxidant effect of moroccan pomegranate ( Punica granatum L. Sefri Variety) extracts rich in punicalagin against the oxidative stress process. Foods, 2021, 10: 2219. https://doi.org/10.3390/foods10092219

Koponen, J. M., Happonen A. M., Mattila, P. H., et al. Contents of anthocyanins and ellagitannins in selected foods consumed in Finland. Journal of Agricultural and Food Chemistry, 2007, 55: 1612–16199. https://doi.org/10.1021/jf062897a

Määttä-Riihinen, K. R., Kamal-Eldin A., Törrönen, A. R. Identification and quantification of phenolic compounds in berries of Fragaria and Rubus species (family Rosaceae). Journal of Agricultural and Food Chemistry, 2004, 52: 6178–6187. https://doi.org/10.1021/jf049450r

Zafrilla, P., Ferreres F., Tomás-Barberán, F. A. Effect of processing and storage on the antioxidant ellagic acid derivatives and flavonoids of red raspberry ( Rubus idaeus) jams. Journal of Agricultural and Food Chemistry, 2001, 49: 3651–3655. https://doi.org/10.1021/jf010192x

Williams, D. J., Edwards, D., Pun, S., et al. Profiling ellagic acid content: The importance of form and ascorbic acid levels. Food Research International, 2014, 66: 100–106. https://doi.org/10.1016/j.foodres.2014.09.003

Wada, L., Ou, B. Antioxidant activity and phenolic content of Oregon caneberries. Journal of Agricultural and Food Chemistry, 2002, 50: 3495–500. https://doi.org/10.1021/jf011405l

Konczak, I., Maillot, F., Dalar, A. Phytochemical divergence in 45 accessions of Terminalia ferdinandiana (Kakadu plum). Food Chemistry, 2014, 151: 248–256. https://doi.org/10.1016/j.foodchem.2013.11.049

Williams, D. J., Edwards, D., Pun, S., et al. Organic acids in Kakadu plum ( Terminalia ferdinandiana): The good (ellagic), the bad (oxalic) and the uncertain (ascorbic). Food research international (Ottawa, Ont.), 2016, 89: 237–244. https://doi.org/10.1016/j.foodres.2016.08.004

Lee, J. H., Johnson J. V., Talcott, S. T. Identification of ellagic acid conjugates and other polyphenolics in muscadine grapes by HPLC-ESI-MS. Journal of Agricultural and Food Chemistry, 2005, 53: 6003–10. https://doi.org/10.1021/jf050468r

Filomena Monica, V., Luigi De, M., Roberto, C., et al. Valorization of the agro-forestry wastes from Italian chestnut cultivars for the recovery of bioactive compounds. European Food Research and Technology, 2019, 245: 2679–2686. https://doi.org/10.1007/s00217-019-03379-w

Borowski, J., Szajdek, A., Borowska, E. J., et al. Content of selected bioactive components and antioxidant properties of broccoli ( Brassica oleracea L.). European Food Research and Technology, 2008, 226: 459–465. https://doi.org/10.1007/s00217-006-0557-9

Cangussu, L. B., Leao, D. P., Oliveira, L. S., et al. Profile of bioactive compounds in pequi ( Caryocar brasilense Camb.) peel flours. Food Chemistry, 2021, 350: 129221. https://doi.org/10.1016/j.foodchem.2021.129221

Abd-Elkader, D. Y., Mohamed, A. A., Feleafel, M. N., et al. Photosynthetic pigments and biochemical response of Zucchini ( Cucurbita pepo L.) to plant-derived extracts, microbial, and potassium silicate as biostimulants under greenhouse conditions. Frontiers in Plant Science, 2022, 13: 879545. https://doi.org/10.3389/fpls.2022.879545

Rangkadilok, N., Sitthimonchai, S., Worasuttayangkurn, L., et al. Evaluation of free radical scavenging and antityrosinase activities of standardized longan fruit extract. Food and Chemical Toxicology, 2007, 45: 328–336. https://doi.org/10.1016/j.fct.2006.08.022

Lee, J. H., Talcott, S. T. Fruit maturity and juice extraction influences ellagic acid derivatives and other antioxidant polyphenolics in muscadine grapes. Journal of Agricultural and Food Chemistry, 2004, 52: 361–366. https://doi.org/10.1021/jf034971k

Yang, X., Tomás-Barberán, F. A. Tea is a significant dietary source of ellagitannins and ellagic acid. Journal of Agricultural and Food Chemistry, 2019, 67: 5394–5404. https://doi.org/10.1021/acs.jafc.8b05010

Mondal H., Saha, S., Awang, K., et al. Central-stimulating and analgesic activity of the ethanolic extract of Alternanthera sessilis in mice. BMC Complementary and Alternative Medicine, 2014, 14: 398. https://doi.org/10.1186/1472-6882-14-398

Nawirska-Olszańska, A., Zaczyńska, E., Czarny, A., et al. Chemical characteristics of ethanol and water extracts of black alder ( Alnus glutinosa L.) acorns and their antibacterial, anti-fungal and antitumor properties. Molecules, 2022, 27: 2804. https://doi.org/10.3390/molecules27092804

Guo, Q. M., Yang, X. W. A new ellagic acid derivative from the fruits of Eucalyptus globulus Labill. Die Pharmazie, 2005, 60: 708–710.

Ma, S., Qin, H., Jiang, M., et al. Identification and comparison of tannins in gall of Rhus chinensis Mill. and Gall of Quercus infectoria Oliv. by High-Performance Liquid Chromatography-Electrospray Mass Spectrometry. Journal of chromatographic science, 2020, 58: 403–410. https://doi.org/10.1093/chromsci/bmz096

Iwaoka, Y., Suzuki, S., Kato, N., et al. Characterization and Identification of Bioactive Polyphenols in the Trapabispinosa Roxb. Pericarp Extract. Molecules, 2021, 26: 5802. https://doi.org/10.3390/molecules26195802

Yang, Z., Yue, S. J., Gao, H., et al. Natural deep eutectic solvent-ultrasound assisted extraction: A green approach for ellagic acid extraction from Geum japonicum. Frontiers In Nutrition, 2023, 9: 1079767. https://doi.org/10.3389/fnut.2022.1079767

Sarker, U., Oba, S. Phenolic profiles and antioxidant activities in selected drought-tolerant leafy vegetable amaranth. Scientific Reports, 2020, 10: 18287. https://doi.org/10.1038/s41598-020-71727-y

Espín, J. C., Larrosa, M., García-Conesa, M. T., et al. Biological significance of urolithins, the gut microbial ellagic acid-derived metabolites: the evidence so far. Evidence-based complementary and alternative medicine: eCAM, 2013, 2013: 270418. https://doi.org/10.1155/2013/270418

Bellou, V., Belbasis, L., Tzoulaki, I., et al. Risk factors for type 2 diabetes mellitus: An exposure-wide umbrella review of meta-analyses. PLoS One, 2018, 13: e0194127. https://doi.org/10.1371/journal.pone.0194127

Stumvoll, M., Goldstein, B. J., van Haeften, T. W. Type 2 diabetes: principles of pathogenesis and therapy. Lancet, 2005, 365: 1333–1346. https://doi.org/10.1016/S0140-6736(05)61032-X

Lizcano, J. M., Alessi, D. R. The insulin signaling pathway. Current Biology, 2002, 12: R236–238. https://doi.org/10.1016/s0960-9822(02)00777-7

Gleason, C. E., Lu, D., Witters, L. A., et al. The role of AMPK and mTOR in nutrient sensing in pancreatic beta-cells. Journal of Biological Chemistry, 2007, 282: 10341–10351. https://doi.org/10.1074/jbc.M610631200

Zhang, W., Hou, C., Du, L., et al. Protective action of pomegranate peel polyphenols in type 2 diabetic rats via the translocation of Nrf2 and FoxO1 regulated by the PI3K/Akt pathway. Food & Function, 2021, 12: 11408–11419. https://doi.org/10.1039/d1fo01213d

Nemati, S., Tadibi, V., Hoseini, R. Pomegranate juice intake enhances the effects of aerobic training on insulin resistance and liver enzymes in type 2 diabetic men: a single-blind controlled trial. BMC Nutrition, 2022, 8: 48. https://doi.org/10.1186/s40795-022-00538-3

Wang, X., Tian, J., Jiang, J., et al. Effects of green tea or green tea extract on insulin sensitivity and glycaemic control in populations at risk of type 2 diabetes mellitus: a systematic review and meta-analysis of randomised controlled trials. Journal of Human Nutrition and Dietetics, 2014, 27: 501–512. https://doi.org/10.1111/jhn.12181

Li, Y., Wang, C., Huai, Q. J., et al. Effects of tea or tea extract on metabolic profiles in patients with type 2 diabetes mellitus: a meta-analysis of ten randomized controlled trials. Diabetes-Metabolism Research and Reviews, 2016, 32: 2–10. https://doi.org/10.1002/dmrr.2641

Chen, G. H., Lin, Y. L., Hsu, W. L., et al. Significant elevation of antiviral activity of strictinin from Pu'er tea after thermal degradation to ellagic acid and gallic acid. Journal of Food and Drug Analysis, 2015, 23: 116–123. https://doi.org/10.1016/j.jfda.2014.07.007

Elbandrawy, M. M., Sweef, O., Elgamal, D, et al. Ellagic acid regulates hyperglycemic state through modulation of pancreatic IL-6 and TNF- α immunoexpression. Saudi Journal of Biological Sciences, 2022, 29: 3871–3880. https://doi.org/10.1016/j.sjbs.2022.03.016

Altındağ, F., Rağbetli, M., Özdek, U., et al. Combined treatment of sinapic acid and ellagic acid attenuates hyperglycemia in streptozotocin-induced diabetic rats. Food and Chemical Toxicology, 2021, 156: 112443. https://doi.org/10.1016/j.fct.2021.112443

Harakeh, S., Almuhayawi, M., Jaouni, S. A., et al. Antidiabetic effects of novel ellagic acid nanoformulation: Insulin-secreting and anti-apoptosis effects. Saudi Journal of Biological Sciences, 2020, 27: 3474–3480. https://doi.org/10.1016/j.sjbs.2020.09.060

Toubal, S., Oiry, C., Bayle, M., et al. Urolithin C increases glucose-induced ERK activation which contributes to insulin secretion. Fundamental & Clinical Pharmacology, 2020, 34: 571–580. https://doi.org/10.1111/fcp.12551

Toney, A. M., Fan, R., Xian, Y., et al. Urolithin A, a Gut metabolite, improves insulin sensitivity through augmentation of mitochondrial function and biogenesis. Obesity, 2019, 27: 612–620. https://doi.org/10.1002/oby.22404

Zhang, Y., Zhang, Y., Halemahebai, G., et al. Urolithin A, a pomegranate metabolite, protects pancreatic β cells from apoptosis by activating autophagy. Journal of Ethnopharmacology, 2021, 272: 113628. https://doi.org/10.1016/j.jep.2020.113628

Kondo, S., Adachi, S. I., Komatsu, W., et al. Antidiabetic effect of urolithin A in cultured L6 myotubes and type 2 diabetic model KK-A(y)/Ta mice with glucose intolerance. Current Issues in Molecular Biology, 2024, 46: 1078–1090. https://doi.org/10.3390/cimb46020068

Polce, S. A., Burke, C., França, L. M., et al. Ellagic acid alleviates hepatic oxidative stress and insulin resistance in diabetic female rats. Nutrients, 2018, 10: E531. https://doi.org/10.3390/nu10050531

Yang, J. P., Guo, Y. Q., Henning, S. M., et al. Ellagic acid and its microbial metabolite urolithin A alleviate diet-induced insulin resistance in mice. Molecular Nutrition & Food Research, 2020, 64: e2000091. https://doi.org/10.1093/cdn/nzz031.OR24-03-19

Lontchi-Yimagou, E., Sobngwi, E., Matsha, T. E., et al. Diabetes mellitus and inflammation. Current Diabetes Reports, 2013, 13: 435–444. https://doi.org/10.1007/s11892-013-0375-y

Rohm, T. V., Meier, D. T., Olefsky, J. M., et al. Inflammation in obesity, diabetes, and related disorders. Immunity, 2022, 55: 31–55. https://doi.org/10.1016/j.immuni.2021.12.013

Goldberg, R. B. Cytokine and cytokine-like inflammation markers, endothelial dysfunction, and imbalanced coagulation in development of diabetes and its complications. Journal Of Clinical Endocrinology & Metabolism, 2009, 94: 3171–3182. https://doi.org/10.1210/jc.2008-2534

An, Y., Xu, B. T., Wan, S. R., et al. The role of oxidative stress in diabetes mellitus-induced vascular endothelial dysfunction. Cardiovascular Diabetology, 2023, 22: 237. https://doi.org/10.1186/s12933-023-01965-7

Shahidi, S., Komaki, A., Raoufi, S., et al. The anti-nociceptive effect of ellagic acid in streptozotocin-induced hyperglycemic rats by oxidative stress involvement. Basic and Clinical Neuroscience, 2021, 12: 861–872. https://doi.org/10.32598/bcn.2021.2413.1

Zhou, B., Li, Q., Wang, J., et al. Ellagic acid attenuates streptozocin induced diabetic nephropathy via the regulation of oxidative stress and inflammatory signaling. Food and Chemical Toxicology, 2019, 123: 16–27. https://doi.org/10.1016/j.fct.2018.10.036

Ahad, A., Ganai, A. A., Mujeeb, M., et al. Ellagic acid, an NF-κB inhibitor, ameliorates renal function in experimental diabetic nephropathy. Chemico-Biological Interactions, 2014, 219: 64–75. https://doi.org/10.1016/j.cbi.2014.05.011

Zhang, Y., Aisker, G., Dong, H., et al. Urolithin A suppresses glucolipotoxicity-induced ER stress and TXNIP/NLRP3/IL-1β inflammation signal in pancreatic β cells by regulating AMPK and autophagy. Phytomedicine, 2021, 93: 153741. https://doi.org/10.1016/j.phymed.2021.153741

Jackson, V. M., Breen, D. M., Fortin, J. P., et al. Latest approaches for the treatment of obesity. Expert Opinion on Drug Discovery, 2015, 10: 825–839. https://doi.org/10.1517/17460441.2015.1044966

Derosa, G., Maffioli, P. Anti-obesity drugs: a review about their effects and their safety. Expert Opinion on Drug Safety, 2012, 11: 459–471. https://doi.org/10.1517/14740338.2012.675326

Berge, J., Hjelmesaeth, J., Hertel, J. K., et al. Effect of aerobic exercise intensity on energy expenditure and weight loss in severe obesity-a randomized controlled trial. Obesity, 2021, 29: 359–369. https://doi.org/10.1002/oby.23078

Wen, X., Zhang, B., Wu, B., et al. Signaling pathways in obesity: mechanisms and therapeutic interventions. Signal Transduction and Targeted Therapy, 2022, 7: 298. https://doi.org/10.1038/s41392-022-01149-x

Wang, L., Li, L., Ran, X., et al. Ellagic acid reduces adipogenesis through inhibition of differentiation-prevention of the induction of Rb phosphorylation in 3T3-L1 adipocytes. Evidence-based Complementary and Alternative Medicine, 2013, 2013: 287534. https://doi.org/10.1155/2013/287534

Woo, M. S., Choi, H. S., Seo, M. J., et al. Ellagic acid suppresses lipid accumulation by suppressing early adipogenic events and cell cycle arrest. Phytotherapy Research, 2015, 29: 398–406. https://doi.org/10.1002/ptr.5264

Rahimi Naiini, M., Shahouzehi, B., Khaksari, M., et al. Ellagic acid reduces hepatic lipid contents through regulation of SIRT1 and AMPK in old rats. Archives of Physiology and Biochemistry, 2023, 10: 1–8. https://doi.org/10.1080/13813455.2023.2262165

Abdulrahman, A. O., Kuerban, A., Alshehri, Z. A., et al. Urolithins attenuate multiple symptoms of obesity in rats fed on a high-fat diet. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 2020, 13: 3337–3348. https://doi.org/10.2147/dmso.S268146

Jeremic, N., Chaturvedi, P., Tyagi, S. C. Browning of white fat: novel insight into factors, mechanisms, and therapeutics. Journal Of Cellular Physiology, 2017, 232: 61–68. https://doi.org/10.1002/jcp.25450

Wang, W., Seale, P. Control of brown and beige fat development. Nature Reviews Molecular Cell Biology, 2016, 17: 691–702. https://doi.org/10.1038/nrm.2016.96

Park, W. Y., Choe, S. K., Park, J., et al. Black raspberry ( Rubus coreanus Miquel) promotes browning of preadipocytes and inguinal white adipose tissue in cold-induced mice. Nutrients, 2019, 11: 2164. https://doi.org/10.3390/nu11092164

Wang, L., Wei, Y., Ning, C., et al. Ellagic acid promotes browning of white adipose tissues in high-fat diet-induced obesity in rats through suppressing white adipocyte maintaining genes. Endocrine Journal, 2019, 66: 923–936. https://doi.org/10.1507/endocrj.EJ18-0467

Park, W. Y., Park, J., Ahn, K. S., et al. Ellagic acid induces beige remodeling of white adipose tissue by controlling mitochondrial dynamics and SIRT3. FASEB Journal, 2021, 35: e21548. https://doi.org/10.1096/fj.202002491R

Xia, B., Shi, X. C., Xie, B. C., et al. Urolithin A exerts antiobesity effects through enhancing adipose tissue thermogenesis in mice. PLoS Biology, 2020, 18: e3000688. https://doi.org/10.1371/journal.pbio.3000688

Hansson, G. K., Hermansson, A. The immune system in atherosclerosis. Nature Immunology, 2011, 12: 204–212. https://doi.org/10.1038/ni.2001

Wu, M., Li, X., Wang, S., et al. Polydatin for treating atherosclerotic diseases: A functional and mechanistic overview. Biomedicine & Pharmacotherapy, 2020, 128: 110308. https://doi.org/10.1016/j.biopha.2020.110308

Kong, P., Cui, Z. Y., Huang, X. F., et al. Inflammation and atherosclerosis: signaling pathways and therapeutic intervention. Signal Transduction and Targeted Therapy, 2022, 7: 131. https://doi.org/10.1038/s41392-022-00955-7

Michicotl-Meneses, M. M., Thompson-Bonilla, M. D. R., Reyes-López, C. A., et al. Inflammation markers in adipose tissue and cardiovascular risk reduction by pomegranate juice in obesity induced by a hypercaloric diet in wistar rats. Nutrients, 2021, 13: 2577. https://doi.org/10.3390/nu13082577

Lee, W. J., Ou, H. C., Hsu, W. C., et al. Ellagic acid inhibits oxidized LDL-mediated LOX-1 expression, ROS generation, and inflammation in human endothelial cells. Journal of Vascular Surgery, 2010, 52: 1290–1300. https://doi.org/10.1016/j.jvs.2010.04.085

Mele, L., Mena, P., Piemontese, A., et al. Antiatherogenic effects of ellagic acid and urolithins in vitro. Archives of Biochemistry and Biophysics, 2016, 599: 42–50. https://doi.org/10.1016/j.abb.2016.02.017

Han, Q. A., Yan, C., Wang, L., et al. Urolithin A attenuates ox-LDL-induced endothelial dysfunction partly by modulating microRNA-27 and ERK/PPAR-γ pathway. Molecular nutrition & food research, 2016, 60: 1933–1943. https://doi.org/10.1002/mnfr.201500827

Wang, H. H., Garruti, G., Liu, M., et al. Cholesterol and Lipoprotein Metabolism and Atherosclerosis: Recent Advances In reverse Cholesterol Transport. Annals of Hepatology, 2017, 16: s27–s42. https://doi.org/10.5604/01.3001.0010.5495

Ou, H. C., Lee, W. J., Lee, S. D., et al. Ellagic acid protects endothelial cells from oxidized low-density lipoprotein-induced apoptosis by modulating the PI3K/Akt/eNOS pathway. Toxicology and Applied Pharmacology, 2010, 248: 134–143. https://doi.org/10.1016/j.taap.2010.07.025

Park, S. H., Kang, M. K., Kim, D. Y., et al. Ellagic acid, a functional food component, ameliorates functionality of reverse cholesterol transport in murine model of atherosclerosis. Nutrition Research and Practice, 2024, 18: 194–209. https://doi.org/10.4162/nrp.2024.18.2.194

Yu, Y. M., Chang, W. C., Wu, C. H., et al. Reduction of oxidative stress and apoptosis in hyperlipidemic rabbits by ellagic acid. Journal of Nutritional Biochemistry, 2005, 16: 675–681. https://doi.org/10.1016/j.jnutbio.2005.03.013

Cui, G. H., Chen, W. Q., Shen, Z. Y. Urolithin A shows anti-atherosclerotic activity via activation of class B scavenger receptor and activation of Nef2 signaling pathway. Pharmacological Reports, 2018, 70: 519–524. https://doi.org/10.1016/j.pharep.2017.04.020

Han, Q. A., Su, D., Shi, C., et al. Urolithin A attenuated ox-LDL-induced cholesterol accumulation in macrophages partly through regulating miR-33a and ERK/AMPK/SREBP1 signaling pathways. Food & Function, 2020, 11: 3432–3440. https://doi.org/10.1039/c9fo02471a

Kattoor, A. J., Pothineni, N. V. K., Palagiri, D., et al. Oxidative stress in atherosclerosis. Current Atherosclerosis Reports, 2017, 19: 42. https://doi.org/10.1007/s11883-017-0678-6

Duan, H., Zhang, Q., Liu, J., et al. Suppression of apoptosis in vascular endothelial cell, the promising way for natural medicines to treat atherosclerosis. Pharmacological Research, 2021, 168: 105599. https://doi.org/10.1016/j.phrs.2021.105599

Ding, Y., Zhang, B., Zhou, K., et al. Dietary ellagic acid improves oxidant-induced endothelial dysfunction and atherosclerosis: role of Nrf2 activation. International Journal of Cardiology, 2014, 175: 508–514. https://doi.org/10.1016/j.ijcard.2014.06.045

Rani, U. P., Kesavan, R., Ganugula, R., et al. Ellagic acid inhibits PDGF-BB-induced vascular smooth muscle cell proliferation and prevents atheroma formation in streptozotocin-induced diabetic rats. Journal of Nutritional Biochemistry, 2013, 24: 1830–1839. https://doi.org/10.1016/j.jnutbio.2013.04.004

Spigoni, V., Mena, P., Cito, M., et al. Effects on nitric oxide production of urolithins, gut-derived ellagitannin metabolites, in human aortic endothelial cells. Molecules, 2016, 21: 1009. https://doi.org/10.3390/molecules21081009

Rong, L., Zou, J., Ran, W., et al. Advancements in the treatment of non-alcoholic fatty liver disease (NAFLD). Frontiers in Endocrinology, 2022, 13: 1087260. https://doi.org/10.3389/fendo.2022.1087260

Smith, B. W., Adams, L. A. Non-alcoholic fatty liver disease. Critical Reviews in Clinical Laboratory Sciences, 2011, 48: 97–113. https://doi.org/10.3109/10408363.2011.596521

Guo, X., Yin, X., Liu, Z., et al. Non-alcoholic fatty liver disease (NAFLD) pathogenesis and natural products for prevention and treatment. International Journal of Molecular Sciences, 2022, 23: 15489. https://doi.org/10.3390/ijms232415489

Qin, Y., Fan, R., Liu, Y., et al. Exploring the potential mechanism of Rubus corchorifolius L. fruit polyphenol-rich extract in mitigating non-alcoholic fatty liver disease by integration of metabolomics and transcriptomics profiling. Food & Function, 2023, 14: 9295–9308. https://doi.org/10.1039/d3fo02653a

Huang, C. Z., Tung, Y. T., Hsia, S. M., et al. The hepatoprotective effect of Phyllanthus emblica L. fruit on high fat diet-induced non-alcoholic fatty liver disease (NAFLD) in SD rats. Food & Function, 2017, 8: 842–850. https://doi.org/10.1039/c6fo01585a

Battisti, U. M., Gao, C., Akladios, F., et al. Ellagic acid and its metabolites as potent and selective allosteric inhibitors of liver pyruvate kinase. Nutrients, 2023, 15: 577. https://doi.org/10.3390/nu15030577

ALTamimi, J. Z., Alshammari, G. M., AlFaris, N. A., et al. Ellagic acid protects against non-alcoholic fatty liver disease in streptozotocin-diabetic rats by activating AMPK. Pharmaceutical Biology, 2022, 60: 25–37. https://doi.org/10.1080/13880209.2021.1990969

Dong, W., Chen, M., Chang, C., et al. Remodeling of tumor microenvironment by nanozyme combined cGAS-STING signaling pathway agonist for enhancing cancer immunotherapy. International Journal of Molecular Sciences, 2023, 24: 13935. https://doi.org/10.3390/ijms241813935

Battisti, U. M., Monjas, L., Akladios, F., et al. Exploration of novel urolithin C derivatives as non-competitive inhibitors of liver pyruvate kinase. Pharmaceuticals, 2023, 16: 668. https://doi.org/10.3390/ph16050668

Doghramji, P. P., Wortmann, R. L. Hyperuricemia and gout: New concepts in diagnosis and management. Postgraduate Medicine, 2012, 124: 98–109. https://doi.org/10.3810/pgm.2012.11.2616

Baker, J. F., Schumacher, H. R. Update on gout and hyperuricemia. International Journal Of Clinical Practice, 2010, 64: 371–377. https://doi.org/10.1111/j.1742-1241.2009.02188.x

Wang, W., Pang, J., Ha, E .H., et al. Development of novel NLRP3-XOD dual inhibitors for the treatment of gout. Bioorganic & Medicinal Chemistry Letters, 2020, 30: 126944. https://doi.org/10.1016/j.bmcl.2019.126944

Primarizky, H., Yuniarti, W. M., Lukiswanto, B. S. Benefits of pomegranate ( Punica granatum Linn) fruit extracts to weight changes, total protein, and uric acid in white rats (Rattus norvegicus) as an animal model of acute renal failure. Veterinary world, 2016, 9: 1269–1274. https://doi.org/10.14202/vetworld.2016.1269-1274

Chen, J., He, Z., Yu, S., et al. Xanthine oxidase inhibitory kinetics and mechanism of ellagic acid: In vitro, in silico and in vivo studies. IET nanobiotechnology, 2023, 17: 368–375. https://doi.org/10.1049/nbt2.12135

Elseweidy, M. M., Elesawy, A. E., Sobh, M. S., et al. Ellagic acid ameliorates high fructose-induced hyperuricemia and non-alcoholic fatty liver in Wistar rats: focusing on the role of C1q/tumor necrosis factor-related protein-3 and ATP citrate lyase. Life sciences, 2022, 305: 120751. https://doi.org/10.1016/j.lfs.2022.120751

Hollander, W. Role of hypertension in atherosclerosis and cardiovascular disease. The American journal of cardiology, 1976, 38: 786–800. https://doi.org/10.1016/0002-9149(76)90357-x

Ma, J., Li, Y., Yang, X., et al. Signaling pathways in vascular function and hypertension: molecular mechanisms and therapeutic interventions. Signal Transduction and Targeted Therapy, 2023, 8: 168. https://doi.org/10.1038/s41392-023-01430-7

Butnariu, M., Fratantonio, D., Herrera-Bravo, J., et al. Plant-food-derived bioactives in managing hypertension: from current findings to upcoming effective pharmacotherapies. Current Topics in Medicinal Chemistry, 2023, 23: 589–617. https://doi.org/10.2174/1568026623666230106144509

Wang, D., Özen, C., Abu-Reidah, I. M., et al. Vasculoprotective effects of pomegranate ( Punica granatum L.). Frontiers in Pharmacology, 2018, 9: 544. https://doi.org/10.3389/fphar.2018.00544

Jordão, J. B. R., Porto, H. K. P., Lopes, F. M., et al. Protective effects of ellagic acid on cardiovascular injuries caused by hypertension in rats. Planta medica, 2017, 83: 830–836. https://doi.org/10.1055/s-0043-103281

Berkban, T., Boonprom, P., Bunbupha, S., et al. Ellagic acid prevents L-NAME-induced hypertension via restoration of eNOS and p47phox expression in rats. Nutrients, 2015, 7: 5265–5280. https://doi.org/10.3390/nu7075222

da Silva, F. B., Romero, W. G., Rouver, W. D. N., et al. Ellagic acid prevents vascular dysfunction in small mesenteric arteries of ovariectomized hypertensive rats. The Journal of Nutritional Biochemistry, 2022, 105: 108995. https://doi.org/10.1016/j.jnutbio.2022.108995

Zhang C., Song, Y., Yuan, M., et al. Ellagitannins-derived intestinal microbial metabolite urolithin A ameliorates fructose-driven hepatosteatosis by suppressing hepatic lipid metabolic reprogramming and inducing lipophagy. Journal of Agricultural and Food Chemistry, 2023, 71: 3967–3980. https://doi.org/10.1021/acs.jafc.2c05776